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ABSTRACT
Bacteria and bacteriophages have evolved DNA
modification as a strategy to protect their
genomes. Mom protein of bacteriophage Mu
modifies the phage DNA, rendering it refractile to
numerous restriction enzymes and in turn enabling
the phage to successfully invade a variety of hosts.
A strong fortification, a combined activity of
the phage and host factors, prevents untimely
expression of mom and associated toxic effects.
Here, we identify the bacterial chromatin archi-
tectural protein Fis as an additional player in this
crowded regulatory cascade. Both in vivo and
in vitro studies described here indicate that Fis
acts as a transcriptional repressor of mom
promoter. Further, our data shows that Fis
mediates its repressive effect by denying access
to RNA polymerase at mom promoter. We propose
that a combined repressive effect of Fis and previ-
ously characterized negative regulatory factors
could be responsible to keep the gene silenced
most of the time. We thus present a new facet of
Fis function in Mu biology. In addition to bringing
about overall downregulation of Mu genome, it
also ensures silencing of the advantageous but po-
tentially lethal mom gene.
INTRODUCTION
The temperate bacteriophage Mu infects Escherichia coli
and several other enteric bacteria (1). One of the factors
contributing to the wide host range of Mu is a novel
post-replicative DNA modification function encoded by
the phage gene mom (2–4). Sequence specific modification
of adenine to N-6 acetamidoadenine by the gene product
of mom renders the phage DNA resistant to several host
encoded restriction/modification systems (5). Expression
of mom, a late function in the lytic cycle of Mu, is cyto-
toxic to the host (6–8). An elaborate regulatory network
has evolved to curb untimely mom expression
(Supplementary Figure S1) (9). While Com (product of
the overlapping com ORF within the mom operon) is es-
sential to achieve translation of mom mRNA (8,10,11), a
complex interplay between the host proteins Dam (DNA
adenine methyltransferase) and OxyR governs transcrip-
tion from mom promoter (Pmom) (12–14). In addition,
owing to factors like suboptimal spacing between the
poor 35 and 10 elements and intrinsic curvature
conferred by a T stretch, Pmom is far from being a classical
promoter and is dependent on transcription activator C
(15–17). Furthermore, activation of the activator C itself is
subject to availability of Mg+2 (18). Moreover, in the
absence of C protein, RNA polymerase (RNAP) gets re-
cruited at a divergent overlapping promoter momP2, thus
posing competition to the already weak mom promoter
(17,19).
The simultaneous existence of multiple mechanisms to
fine-tune a single phage function might seem excessive.
For instance, despite the existence of a multi-layered tran-
scriptional control, a further check at the translational
level appears needless. However, to restrain mom gene
from exerting its cytotoxic effect, its expression must be
precisely modulated. The currently known mom regula-
tory circuit is not only elaborate but also apparently
failsafe (9). In this article, we report a hitherto unidentified
mechanism operating to add to the fortification. While
characterizing the role of the transactivator C, we
observed a Pmom specific DNA binding activity in crude
cell extracts of E. coli (Figure 1A, V. Ramesh, unpublished
data). This observation prompted us to identify the host
factor and investigate the possibility of it regulating the
expression of mom. Here, we have elucidated the role of
this new player in mom regulation.
MATERIALS AND METHODS
Bacterial strains and plasmids
The bacterial strains and plasmids used in this study are as
described in Supplementary Table S1.
Electrophoretic Mobility Shift Assay
End labeled Pmom DNA was incubated with variable
amounts of cell extracts or purified protein in TMEG100
buffer [20mM Tris–HCl (pH 7.4), 5mM MgCl2, 1mM
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EDTA (pH 8.0), 10% glycerol, 100mM NaCl, 5mM
b-mercaptoethanol] for 10min on ice. Loading buffer
[20mM Tris–HCl (pH 7.5), 10% glycerol] containing
0.01% bromophenol blue and 0.01% xylene cyanol was
added to the reaction and the samples were analyzed on
4 or 8% native polyacrylamide gels (30:0.8) in 0.5
TBE buffer [45mM Tris–borate, 1mM EDTA (pH 8.3)]
at 4C.
Figure 1. Identification of the host factor that binds specifically to Pmom. (A) Pmom specific activity in crude cell extracts of E. coli. End-labeled
260-bp Pmom fragment (lane 1) was incubated with 220 nM purified C (lane 2) and 1 mg of crude sonicated extract (lane 3) and partially purified cell
extract (lane 4) of E. coli MG1655. Lane 5 onwards, PvuI digested Pmom (lane 5) was incubated with 220 nM purified C (lane 6) and 1 mg of crude
sonicated extract (lane 7) and partially purified cell extract (lane 8) of E. coli MG1655. EMSAs with cell extracts were carried out in the presence of
200 ng poly (dI – dC). Mobility shift caused by binding of C is depicted by asterisks while that caused by the unknown host factor is depicted by bold
arrows. (B) Pmom fragment used for EMSAs. A 260-bp fragment of Pmom obtained upon digestion of plasmid pUW4 with EcoRI and HindIII was
radiolabeled at both the 30-ends (denoted by asterisks) by Klenow polymerase-mediated end filling. Digestion of this fragment with PvuI yields three
fragments of sizes 60, 18 and 182 bp of which only the terminal fragments (60 and 182 bp) carry the radiolabel. The larger fragment (182 bp) contains
the C-binding site whereas the smaller fragment (60 bp) comes from the upstream region. (C) Effect of ionic strength on stability of the complex.
220-bp Pmom obtained upon digestion of pUW4 with EcoRI and BamHI (lane 1) was incubated with 1 mg of crude cell extract of E. coli MG1655 in
the presence of increasing concentrations of NaCl as indicated. The host factor–DNA complex was stable even in 750mM NaCl. (D) Effect of
non-specific competitor DNA on complex formation. End labeled 220 bp Pmom fragment (lane 1) was incubated with 1mg of crude cell extract of
E. coli MG1655 in the presence of 0-, 50- and 100-fold molar excess of three different unlabeled non-specific competitor DNA fragments (lanes 2–10)
and unlabeled Pmom fragment (lanes 11–13). Labeled Pmom DNA is competed by the specific unlabeled Pmom DNA but not by any of the three
non-specific DNA fragments, showing that the complex results from specific binding of a molecule in the extract to Pmom. (E) LC/ESI-MS analysis of
the active fraction. Crude cell extract of E. coli MG1655 was processed as described in ‘Materials and Methods’ section. Eluted fractions from SP
Sepharose column that tested positive for Pmom specific DNA binding activity in EMSA were pooled, dialyzed and subjected to LC/ESI–MS for
whole protein molecular weight detection. Analysis of the fraction revealed a molecular mass of 11.25 kDa.
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Purification of the host factor
Cultures of E. coli MG1655 were grown to log phase
(OD600  0.6) and harvested. About 5 g of cell pellet
was resuspended in 15ml lysis buffer [20mM Tris–HCl
(pH 7.4), 5mM MgCl2, 1mM EDTA (pH 8.0), 10%
glycerol, 500mM NaCl, 200 mg/ml lysozyme, 5mM
b-mercaptoethanol] and sonicated on ice. The extract
was centrifuged at 100 000g for 2 h. An aliquot of the
supernatant (crude cell extract) was used for
Electrophoretic Mobility Shift Assays (EMSAs) and the
rest was proceeded with as follows. Nucleic acids were
precipitated using 1% (v/v) polyethyleneimine (pH 8.0).
Hereafter, at each step of purification, fractions contain-
ing the host factor were selected based on their ability to
bind Pmom in EMSA. Proteins in the extract were
fractionated by a 0–65% saturated ammonium sulfate
cut. The precipitated solution was spun down and the
pellet was resuspended and dialyzed against TMEG100
buffer. The dialyzed fraction was mixed overnight
with 5ml pre-equilibrated phosphocellulose matrix
(Whatman). After a wash with 10ml TMEG100 buffer,
elution was carried out with 5ml TMEG1000 buffer
[20mM Tris–HCl (pH 7.4), 5mM MgCl2, 1mM EDTA
(pH 8.0), 10% glycerol, 1M NaCl]. The eluate was
equilibrated in TMEG100 and passed through 1ml SP
sepharose column (GE Healthcare). Eluted fractions pos-
sessing Pmom specific DNA binding activity were pooled,
dialyzed against 10mM Tris–HCl (pH 7.4), lyophilized
and subjected to micro LC ESI-MS (Bruker apex-ultra
mass spectrometer) for whole protein molecular weight
detection.
Proteins
C protein was overproduced from pVR7 in E. coli
BL21(DE3) and purified as described earlier (20). RNAP
was purified from E. coli K12 MG1655 as described (21).
Fis was overproduced from the IPTG inducible lac pro-
moter in pUHE25-2fis (22) in E. coli W3110 (23). The
protocol described by Osuna et al. (24) was modified
to include the cation exchangers phosphocellulose,
sulfopropyl sepharose and heparin sepharose to purify
Fis. Protein concentration was estimated by the method
of Bradford (25) as well as by analyzing on SDS–PAGE
gel. Restriction enzymes and DNA modifying enzymes
were obtained from New England Biolabs.
In vitro transcription
Multiple round run-off transcription reactions were
carried out using the linear 327 bp mom or tin7 promoter
fragments (spanning the promoter from positions 136 to
+79 relative to mom +1 start site; PCR amplified from
pUW4mom and pUW4tin7 (20,26), respectively, using
pUC forward and reverse primers). For generating tran-
scription templates with specific promoter regions deleted,
the full-length promoter fragment (described earlier) was
digested with BstUI or PvuI followed by extraction from
agarose gel. Fis, at indicated concentrations was incubated
on ice with 40 nM template DNA in transcription buffer
[40mM Tris–HCl (pH 8.0), 5mM magnesium acetate,
0.1mM EDTA, 0.1mM DTT, 100mM KCl, 100mg/ml
BSA] for 5min. C protein was included wherever
indicated. RNAP (100 nM) was added to the reaction
and closed complex was allowed to form for 10min on
ice. The reactions were then shifted to 37C for 10min
to allow open complex formation. Transcription was
initiated by adding 4 mCi [a32P]ATP and 0.3mM NTP
mix and the reactions were allowed to proceed at 37C
for 30min. Reactions were terminated by the addition of
20 ml urea loading dye (8M urea, 0.05% bromophenol
blue, 0.05% xylene cyanol), heated to 65C for 5min
and quenched on ice. Samples were loaded on 8% urea
polyacrylamide gels and analyzed by phosphorimaging.
[a-32P]ATP was purchased from Perkin–Elmer Life
Sciences. NTPs and dNTPs were obtained from GE
Healthcare.
Closed complex formation assays
50 32P labeled 78-bp Ptin7 promoter fragments (wild-type or
with mutations in Fis binding sites) extending from pos-
itions 58 to+20 relative to+1 start site (Supplementary
Figure S2) were incubated with indicated concentrations
of Fis in transcription buffer for 10min on ice. RNAP
(20 nM) was added and further incubated for 10min on
ice. The reactions were analyzed on 5% (w/v) native poly-
acrylamide gels and visualized by phosphorimaging.
DNase I footprinting
Plasmid pUW4 (0.3 pmol) was incubated on ice with
indicated concentrations of Fis for 30min in footprinting
buffer [10mM Tris–HCl (pH 7.6), 2.5mMMgCl2, 0.5mM
CaCl2]. DNase I (0.05U, NEB) was added and incubated
for 30 s at 25C. Reactions were terminated by the
addition of stop buffer [100mM Tris–HCl (pH 7.5),
25mM EDTA, 0.5% SDS]. Samples were deproteinized
by successive extractions with phenol/chloroform/
isoamylalcohol (25:24:1) and chloroform/isoamylalcohol
(24:1). DNA was ethanol precipitated in the presence of
glycogen as a carrier and primer extension was carried out
as described by Gralla (27). Briefly, DNase I treated DNA
samples were used as templates for extension with Klenow
polymerase using end-labeled mom reverse primer (50 GG
AATCCGCCTTAAATAACA 30), which anneals down-
stream of the +56 position with respect to the +1 tran-
scription start site of mom. Samples were ethanol
precipitated and resuspended in 4 ml of formamide
loading dye. After denaturation at 95C for 5min,
samples were electrophoresed on 8% urea polyacrylamide
gels alongside dideoxy sequencing reactions and analyzed
by phosphorimaging.
Construction of pLW4tin7 plasmids with mutations
in Fis binding sites
The plasmid pLW4tin7 harbors Ptin7 extending from pos-
itions 136 to +79 (with respect to mom transcription
start point) cloned in pNM480, resulting in a transcrip-
tional fusion of Ptin7 with lacZ (19). Mutant plasmids
pLW4tin7 FBS 49 38, FBS 49 38+3 and FBS+3
were generated by the megaprimer method for
site-directed mutagenesis using the plasmid pLW4tin7
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as template. Sequences of oligonucleotides used for
megaprimer generation are listed in Supplementary
Table S2. The mutagenic megaprimers were then used in
the Stratagene QuickChangeTM side-directed mutagenesis
method using Phusion high fidelity DNA polymerase
(Finnzymes) to obtain mutant plasmids. Mutations
introduced thus were confirmed by DNA sequencing.
b-Galactosidase assays
Plasmid borne reporter construct pLW4tin7 (explained in
the previous section) and mutant constructs were
introduced into E. coli CSH50 (28) and CSH50 fis::kan
(29). For assessing the effect of activator C, cells were
transformed with the C encoding plasmid pVN184 (19)
in addition to the reporter construct. Overnight cultures
were diluted 1:50 into fresh LB media containing appro-
priate antibiotics and incubated at 37C until their OD600
readings were between 0.3 and 0.5. b-galactosidase activity
was assayed as described (28). Assays were carried out
in triplicate for each culture and the average values
plotted.
RESULTS
Pmom-specific DNA binding activity in E. coli cell extracts
The finding that a host protein binds to Pmom came across
serendipitously during the course of our earlier studies
investigating the role of transactivator C. A 260-bp
fragment encompassing Pmom was obtained by digesting
pUW4 with EcoRI and HindIII (Figure 1A, lane 1 and
Supplementary Figure S2). Both the strands of the
fragment were radiolabeled at their 30-ends by Klenow
end-filling. In EMSA with E. coli cell extracts, it was
observed that a host factor bound specifically to the
fragment (Figure 1A, lanes 3 and 4). Notably, binding
of the factor caused only a small shift in the mobility of
Pmom as compared to that caused by the 33kDa
transactivator C dimer (lane 2). We next assessed the
binding region of the host factor. For this purpose, the
Pmom fragment was digested with PvuI, yielding three frag-
ments of sizes 60, 18 and 182 bp (Figure 1A, lane 5 and
Figure 1B). Purified activator C bound only to the larger
(182 bp) fragment, consistent with the location of the C
binding site therein (Figure 1A, lane 6 and Figure 1B). On
the other hand, crude cell extracts bound specifically to the
60-bp fragment indicating that the host factor binds to a
site upstream of the C binding site (Figure 1A, lanes 7
and 8).
Identification of the host factor that binds
specifically to Pmom
In order to identify this unknown factor, we resorted
to isolate it from crude extracts of E. coli. We observed
that the host factor-Pmom complex was stable at high ionic
strength and competitor DNA concentrations (Figure 1C
and D). In addition, its strong affinity to cation exchange
resins was an indicator of its basic nature. We employed a
protocol essentially encompassing cation exchange chro-
matography to isolate the host factor from log phase
cultures of E. coli MG1655 (see ‘Materials and Methods’
section). Mass spectrometric analysis of the final fraction
revealed a mass of 11.25 kDa, precisely the molecular
weight of the nucleoid associated protein Fis
(Figure 1E). To determine if the Pmom specific DNA
binding was indeed due to Fis, we examined DNA
binding activity of the cell extracts from isogenic fis
and fis+ strains JW3229-1 and BW25113, respectively
(30). Specific retardation pattern, as had been observed
first with E. coli MG1655 crude cell extracts was
observed with fis+ strain but not with fis strain
(Figure 2, lanes 3–11). To further ascertain the identity
of the host factor as Fis, we compared the DNA binding
activity in crude cell extracts with that of purified Fis.
Crude extracts were able to retard Pmom DNA to the
same extent as purified Fis, indicating that the host
factor that binds specifically to Pmom was indeed Fis
(Figure 2, lanes 2 and 3).
Effect of Fis on mom promoter activity
Fis, besides modulating chromatin architecture, is known
to influence numerous promoters of E. coli and several
other bacteria (31–33). We hypothesized that specific
binding of Fis could affect the activity of mom
promoter. To test this hypothesis, we conducted in vitro
transcription with mom and tin7 promoters in the presence
or absence of Fis. Activation of mom promoter is depend-
ent on transactivator C. A spontaneous mutant of mom
promoter—tin7 has a single base substitution at 14
position which converts it into an extended 10
promoter and thus activator independent (19). Fis re-
pressed transcription from both Pmom and Ptin7
(Figure 3A) in a concentration dependent manner
(Supplementary Figure S3). In these in vitro reactions,
Fis repressed transcription even in the presence of C
(Figure 3A). However, the repressive effect of Fis was
reversed upon increasing the concentration of the activa-
tor C and transcription was restored to levels observed in
the absence of Fis (Figure 3B and C). From these data, it
is apparent that C can override Fis-mediated repression.
Fis-mediated in vivo repression
We next investigated the in vivo scenario. In order to
assess the impact of Fis on transcription from Pmom, it
was necessary to obviate the requirement for the positive
Figure 2. EMSA with cell extracts of wild-type (fis+) and fis strains.
The 60-bp fragment (from positions 136 to 85) of Pmom (lane 1) was
incubated with 5 nM Fis (lane 2), 1mg of crude extract of E. coli
MG1655 (lane 3), and 1, 5, 10 and 15 mg of crude extracts of E. coli
BW25113 (lanes 4–7, respectively) and isogenic fis strain JW3229-1
(lanes 8–11, respectively). Specific shift as was observed with purified
Fis could be seen with fis+but not with fis extracts. Binding buffer for
all reactions contained 400mM NaCl.
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regulator C. We therefore took advantage of the
C-independent Ptin7 promoter. Plasmid borne reporter
construct pLW4tin7 containing tin7–lacZ fusion was
transformed into E. coli CSH50 wild-type and fis cells
and the b-galactosidase activity was measured.
b-galactosidase levels in fis cells were found to be signifi-
cantly higher than those in the wild-type (fis+) strain
(Figure 4A), consistent with the Fis-mediated transcrip-
tional repression observed in vitro.
To address the opposing effects of Fis and C in vivo and
to see if C could overcome the repression imparted by Fis,
wild-type and fis cells were transformed with the C
encoding plasmid and promoter activity assayed. No sig-
nificant difference in the b-galactosidase levels was
observed between the two strains (Figure 4B) in contrast
to the scenario in the absence of C, shown in Figure 4A.
This finding is in agreement with the in vitro results
indicating that C can counter the repressive effect of Fis
to activate transcription.
DNase I footprinting on Pmom shows multiple Fis
binding sites
DNase I footprinting was employed to map the Fis
binding sites located in Pmom (Figure 5). Fis protected a
region between positions 7 to +12 in the immediate
vicinity of the mom transcription start site as well as an
extended region from 60 to 22. Further upstream, Fis
protected two other regions between positions 107 to
84 and 133 to 115. Besides, addition of Fis also led
to DNase I hypersensitivity around certain positions in the
promoter, consistent with the properties of Fis to induce
conformational changes in DNA (34,35). Inside the limits
of each of the protected regions, a sequence similar to the
consensus Fis binding site was detected (36–40). In the
protected region spanning positions 60 to 22, two
closely spaced sequences matching the Fis consensus site
were detected. Totally, we identified five Fis binding sites
in Pmom centered at positions 123, 98, 49, 38 and
+3, respectively. EMSAs with the promoter fragments and
Figure 3. Effect of Fis on mom promoter activity. (A) Effect of Fis
on in vitro transcription from Pmom and Ptin7. Multiple round run-off
transcription reactions were carried out using linear promoter frag-
ments (136 to +79) Pmom (lanes 1–4) and Ptin7 (lanes 5–8) in the
presence or absence of 200 nM Fis. C (300 nM) was included as
indicated. Transcription reactions were proceeded as described in
‘Materials and Methods’ section. At Ptin7, transcription is observed
even in the absence of C. (B) Effect of C on Fis-mediated tran-
scriptional repression. In vitro transcription reactions using Ptin7
template were carried out with increasing concentrations of C (as
indicated) in the absence (lanes 1 and 2) or presence of Fis (100 nM
in lanes 3–6 and 50 nM in lanes 7–10). (C) Densitometric analysis of
the transcript bands from (B) was carried out and the values
plotted.
Figure 4. Influence of Fis on promoter activity in vivo. (A) b-Galactosidase expression was measured in E. coli CSH50 wild-type and fis strains
containing Ptin7-lacZ fusion reporter construct. b-Galactosidase activity in wild-type cells was 4- to 5-fold lower than in the fis
 strain.
(B) b-Galactosidase activity measured in CSH50 wild-type and fis strains containing the C encoding plasmid in addition to the plasmid borne
Ptin7-lacZ fusion reporter construct.
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purified Fis exhibited a ladder-like appearance, indicative
of multiple Fis binding sites in Pmom, corroborating the
footprinting data (Supplementary Figure S4 and
Figure 6A, lanes 1–6).
Fis excludes RNAP binding in vitro
The occurrence of multiple Fis binding sites spread over
the mom regulatory region together with the observed in-
hibition of transcription suggested that indeed Fis binding
may interfere with interaction of RNAP with the
promoter. It was important at this point to examine if
the transcriptional repression imparted by Fis diminished
upon deletion/mutation of Fis binding sites. The Fis
binding site at 123 (the site involved in Fis binding in
cell extracts, see Figure 1) was targeted first for deletion.
The 327-bp transcription template (encompassing 136 to
+79 region of mom promoter) was digested with BstUI,
removing the Fis binding site at 123 (Supplementary
Figure S2). When this shortened promoter was used as a
template for in vitro transcription, surprisingly, Fis
continued to repress transcription (Supplementary
Figure S5). A similar observation was made upon
removal of the further downstream Fis binding site
centered around 98 using PvuI, thus removing both
the Fis binding sites located at 123 and 98
(Supplementary Figures S2 and S5). From these
analyses, it appeared that the remaining promoter
proximal Fis binding sites (centered at 49, 38 and
+3) might be involved in transcriptional regulation of
the promoter.
In parallel, we investigated the possibility of Fis directly
interfering with RNAP binding. Indeed, one of the various
ways by which Fis represses transcription is by competing
with RNAP for binding to the promoter (41–44). Besides,
the occurrence of three Fis binding sites (centered at 49,
38 and+3, respectively) overlapping the RNAP binding
region substantiated the notion that Fis binding could
pose steric hindrance to the polymerase and thus interfere
with transcription initiation. To pursue this line of inves-
tigation further, we analyzed the effect of Fis on forma-
tion of RNAP closed complex on mom promoter,
employing Ptin7, as it is amenable to closed complex
analysis in the absence of C. Remarkably, at a 78-bp
promoter fragment spanning positions 58 to +20 with
respect to+1 start site, containing Fis binding sites at 49,
38 and+3, we observed that increasing concentrations
of Fis progressively inhibited the binding of RNAP to the
promoter, as evident from a diminishing closed complex
(Figure 6A, lanes 7–12).Thus, Fis appears to
downregulate the promoter activity by denying access to
RNAP at the promoter. To test this further, we disrupted
the above-mentioned Fis binding sites (singly and in com-
bination) and examined the ability of Fis to compete with
RNAP at the respective mutant promoter variants. At
promoter fragments carrying mutations in Fis binding
sites, Fis could no longer compete with RNAP, as
evident by a stable closed complex even in the presence
of high concentrations of Fis (Figure 6B–D). From these
results, it appears that Fis binding at multiple sites in
the promoter region is necessary for efficient repression.
Figure 5. Footprinting analysis of Fis binding at Pmom. (A) DNase I
footprinting analysis of Fis binding sites in Pmom. Plasmid pUW4 was
incubated with Fis (288 and 384 nM in lanes 2 and 3, respectively) prior
to digestion with DNase I. Primer extension was carried out with
Klenow polymerase using mom reverse primer. The vertical bars on
the left side indicate regions protected from DNase I in the presence
of Fis. G, A, T and C refer to Sanger’s dideoxy sequencing ladders of
Pmom obtained using mom reverse primer. Numbers on the right denote
nucleotide positions with respect to the+1 start site of Pmom. DNase I
hypersensitive sites are depicted by arrowheads. (B) Sequence of mom
promoter. Regions protected by Fis are underlined and sequences
matching with the consensus Fis binding site are highlighted with the
central nucleotide emboldened and its position indicated. The 35 and
10 promoter elements are boxed.
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These competition experiments also showed that disrup-
tion of single Fis binding site markedly reduces the ability
of Fis to prevent closed complex formation.
Disruption of Fis binding sites alleviates repression in vivo
Having observed in vitro that disrupting Fis binding sites
renders Fis incapable of competing with RNAP, we next
tested the effect of disruption of these sites on the
promoter activity in vivo. Complete alleviation of
Fis-mediated repression is observed when all the three
Fis binding sites were mutated whereas disruption of the
site at+3 alone or those at 49 and 38 resulted in partial
reduction of repression (Figure 7 and Supplementary
Table S3). Thus, although both in vitro and in vivo lines
of evidence highlight the importance of multiple Fis
binding for maximal repression of transcription, the
effect of disruption of the+3 site singly or those at 49
and 38 is not very pronounced in vivo. Perhaps this dif-
ference could be attributed to the fact that in addition to
the repressive action of Fis, mom is subjected to a complex
array of regulation with other factors also influencing the
promoter activity (Supplementary Figure S1).
DISCUSSION
Fis was first discovered for its role in stimulating Gin
catalyzed inversion of the G segment of phage Mu
genome (45). Three Fis binding sites within the coding
region of gin, the upstream neighbor of mom were
identified in the course of the above investigation
(46–48). These sites are located 550 bp upstream of the
mom transcription start site and are distinct from those
which we report in this study to be involved in regulating
Figure 6. Effect of Fis on closed complex formation on various promoter fragments. (A) Ptin7 (58 to+20 relative to+1 start point) (lane 1) was
incubated with increasing concentrations of Fis as indicated (lanes 2–6). Subsequently, samples were incubated with 20 nM RNAP to allow closed
complex formation (lanes 7–12). Mutant promoter fragments namely Ptin7FBS-49-38 (Fis binding sites at 49 and 38 mutated) (B), Ptin7FBS+3 (Fis
binding site at+3 mutated) (C), Ptin7FBS-49-38+3 (all three Fis binding sites at 49, 38 and+3 mutated) (D) were also examined for the effect of
Fis on closed complex formation at the respective mutant promoters. On the left are schematic depictions of occurrence or disruption of Fis binding
sites in the respective fragments. F denotes free promoter DNA. DNA–protein complexes are indicated.
Figure 7. Effect of disrupting Fis binding sites on Fis-mediated repres-
sion. pLW4tin7 and variants containing mutations in Fis binding sites
were introduced into isogenic strains CSH50 fis and CSH50 wild-type
(fis+)and b-galactosidase activity was measured. Fold repression (the
ratio of the b-galactosidase activity in fis strain to that in fis+
strain) was plotted.
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mom expression. Our study demonstrates that Fis
represses transcription from mom promoter. However, it
would be too presumptuous to attribute a primary regu-
latory role to Fis, given that mom expression is subject to a
multitude of regulatory checkpoints. In addition, mom
promoter presents a classic case of a weak, activator de-
pendent promoter (15). Upstream of mom transcription
start site is a busy area containing one or more binding
sites for proteins Dam, OxyR, C, RNAP and Fis, sub-
jecting the gene to a complex regulatory system
(Supplementary Figure S1). Occlusion of mom promoter
by Fis appears to prevent RNAP recruitment and thus
transcription from Pmom. The present study provides
evidence that Fis, a host nucleoid associated protein has
been employed by the phage to achieve silencing of its
potentially lethal but advantageous function.
Deployment of nucleoid associated proteins as transcrip-
tional silencers could be an effective strategy to maintain
toxic genes like mom in the phage genome.
It is noteworthy that nutrient availability and growth
phase of the bacterial culture have a pronounced effect on
the intracellular concentrations of Fis. Fis levels markedly
fluctuate from over 50 000–100 000 copies per cell in the
early exponential phase or following a nutrient upshift to
less than 100 copies per cell during the stationary phase
and starvation (49). Earlier work has appreciated the role
of Fis in Mu lysogeny. Studies employing the temperature
sensitive mutant repressor cts62 have demonstrated that
Fis aids the repressor in downregulating both early gene
expression and transposition of phage Mu, thus
contributing to maintain the phage in a lysogenic state
(50). Furthermore, earlier observations have indicated
that conditions of limited growth such as starvation and
stationary phase (when Fis levels are low) could favor
spontaneous induction of phage Mu (51,52). In such Fis
depleted situations when the lytic cycle sets in,
Fis-mediated repression of mom can be anticipated to
diminish. In the lysogenic phase, however, there is a re-
quirement to keep the genome silenced and abundance of
Fis could effectively ensure silencing of mom. In other
words, regulation of mom expression by Fis is likely to
be mediated by a change in the protein abundance. Fis
is known to suppress transcription from guaB, crp, fis,
gyrA promoters by directly competing with RNAP
(41–44). Pre-binding of Fis at these promoters impedes
RNAP recruitment on account of steric hindrance. We
suggest that a similar phenomenon of promoter occlusion
by Fis could be responsible for silencing mom expression
(Figure 8). Although it appears that binding of Fis at
multiple sites in mom promoter has a cumulative repres-
sive effect, each site on its own can also exert a partial
negative effect on transcription from this promoter
(Figure 7).
An orchestrated cascade operating at transcriptional
and translational levels regulates mom expression
(Supplementary Figure S1). Most importantly, transcrip-
tion of mom is contingent on C protein, a well-established
activator of Pmom that is expressed only in the middle
phase of the lytic cycle (53). C facilitates RNAP recruit-
ment by realigning the out of phase 35 and 10
Figure 8. Model showing Fis-mediated silencing of mom. The rightmost gene in the Mu genome is mom. Pmom, the regulatory region of mom has
been enlarged. The 35 and 10 promoter elements of Pmom are boxed. The dashed arrows indicate binding of Fis (small oval) to multiple sites in
the promoter (as shown by DNase I footprinting). RNAP (large oval) cannot bind to Pmom because Fis is occluding the RNAP binding region. The
Fis binding sites implicated in interfering with RNAP binding and thus with transcription are indicated by thickened arrows. Effect of Fis on other
regions of the genome (see ‘Discussion’ section) is not shown.
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promoter elements (54). At a further step, C enhances
promoter clearance and overcomes the influence of
negative factors responsible for silencing of mom (55).
Multistep activation of Pmom by C ensures mom expression
at the late lytic phase. This irreversible genetic switch
would have to overcome Fis-mediated repression. Since
the binding region of C and two of the Fis sites overlap
around the 35 region of the promoter, it is likely that
under conditions of Fis abundance and in the lysogenic
state, Fis would predominantly occupy the region. During
the lytic cycle, low concentrations of C might not be suf-
ficient to displace Fis bound to the promoter (Figure 3A).
However, higher concentrations of the activator effective-
ly promote RNAP recruitment and activity, evident from
the significant stimulation of transcription brought about
by increased concentrations of C even in the presence of
inhibitory concentrations of Fis (Figure 3B and C).
RNAP recruited at the promoter would also compete
out Fis bound to the downstream site. Thus, the activator
and the polymerase seem to join hands to overcome the
repression imparted by Fis.
Silencing of Pmom by Fis is important in yet another
context. Promoter-up mutations are not uncommon in
nature. Spontaneous emergence of promoter-up muta-
tions in Pmom during lysogeny would result in premature
mom expression and death of the host. The role of Fis in
silencing mom becomes especially important during the
lysogenic state to avoid the lethal effects of untimely ex-
pression arising due to promoter mutations. The ability of
Fis to repress transcription from Ptin7, an activator inde-
pendent and spontaneous promoter-up mutant of Pmom
emphasizes its importance as a silencer of mom, capable
of eliminating any leaky expression from the promoter.
Thus, Fis appears to play a dual role in Mu lysogeny;
not only does it contribute to overall silencing of gene
expression and transposition but also represses a toxic
gene of Mu. We propose that Fis-mediated repression
adds an additional layer to the already elaborate mom
regulatory circuit. After all, the selective advantage
imparted by the anti-restriction function of mom can
outweigh the risk associated with its untimely expression
by silencing of this cytotoxic gene till the late lytic phase.
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